Capital Flow Monitor · Sponsors · CIK 1829982
Iantrek, Inc.
151 EAST POST ROAD, WHITE PLAINS, NY, 10601 · 9147086540
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$42.0M
Sold
$34.7M
% sold
82.8%
Investors
21
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-08-21 | D ·current | 506(b) | $42.0M | $34.7M | 82.8% | 21 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Michael Haydin — Executive Officer, White Plains, NY
1 other raise
- KYS Vision, Inc. $2.2M of $3.3M · 67.0%
-
Marc-Andre Marcotte — Director, Montreal, A8
3 other raises
- Cagent Vascular, Inc. $24.5M of $41.0M · 59.7%
- Miach Orthopaedics Inc. $7.5M of $15.0M · 50.0%
- Neuros Medical, Inc. $56.0M of $65.0M · 86.2%
- Farrell Tyson — Director, Cape Coral, FL
-
Tsontcho Ianchulev — Executive Officer / Director, White Plains, NY
1 other raise
- KYS Vision, Inc. $2.2M of $3.3M · 67.0%
-
James Mazzo — Director, Laguna Beach, CA
2 other raises
- Neurotrigger Ltd. $725K of $725K · 100.0%
- KYS Vision, Inc. $2.2M of $3.3M · 67.0%
- Jeffry K. Weinhuff — Director, Aliso Viejo, CA
-
Robert Weinreb — Director, Rancho Santa Fe, CA
1 other raise
- KYS Vision, Inc. $2.2M of $3.3M · 67.0%
- Adam Szaronos — Executive Officer / Director, Keller, TX
- Todd Sone — Director, Beit Gamla B, Ra'anana, L3
-
Casey Tansey — Director, Menlo Park, CA
3 other raises
- U.S. Venture Partners XIV, L.P. $0 of $400.0M · 0.0%
- Cagent Vascular, Inc. $24.5M of $41.0M · 59.7%
- Neuros Medical, Inc. $56.0M of $65.0M · 86.2%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.